Caffeine Has Similar Pharmacokinetics and Behavioral Effects via the IP and PO Routes of Administration
暂无分享,去创建一个
[1] J. Axelrod,et al. The fate of caffeine in man and a method for its estimation in biological material. , 1953, The Journal of pharmacology and experimental therapeutics.
[2] J. Falk,et al. Tolerance to oral and IP caffeine: Locomotor activity and pharmacokinetics , 1994, Pharmacology Biochemistry and Behavior.
[3] Charles J. Meliska,et al. Caffeine and nicotine: Differential effects on ambulation, rearing and wheelrunning , 1984, Pharmacology Biochemistry and Behavior.
[4] J. Falk,et al. Differential reinforcement of low rate performance, pharmacokinetics and pharmacokinetic-pharmacodynamic modeling: independent interaction of alprazolam and caffeine. , 1997, The Journal of pharmacology and experimental therapeutics.
[5] Stephen G. Holtzman,et al. Tolerance to behavioral effects of caffeine in rats , 1988, Pharmacology Biochemistry and Behavior.
[6] G. Marek,et al. Effects of caffeine and PD 116,600 on the differential-reinforcement-of-low rate 72-S (DRL 72-S) schedule of reinforcement , 1993, Pharmacology Biochemistry and Behavior.
[7] G. K. Mumford,et al. Qualitative differences in the discriminative stimulus effects of low and high doses of caffeine in the rat. , 1991, The Journal of pharmacology and experimental therapeutics.
[8] W. Parsons,et al. Stimulation of caffeine metabolism in the rat by 3-methylcholanthrene. , 1977, Life sciences.
[9] J. Falk,et al. Dose-dependent surmountability of locomotor activity in caffeine tolerance , 1995, Pharmacology Biochemistry and Behavior.
[10] D. Rodbard,et al. Simultaneous analysis of families of sigmoidal curves: application to bioassay, radioligand assay, and physiological dose-response curves. , 1978, The American journal of physiology.
[11] M. Danhof,et al. Pharmacokinetic‐pharmacodynamic modelling of the EEG effects of midazolam in individual rats: influence of rate and route of administration , 1991, British journal of pharmacology.
[12] M. Bonati,et al. Interspecies Comparison of Caffeine Disposition , 1984 .
[13] W. Burkard,et al. Pharmacology of midazolam. , 1981, Arzneimittel-Forschung.
[14] Dennis Webb,et al. Effects of caffeine on DRL performance in the mouse , 1978, Pharmacology Biochemistry and Behavior.
[15] P. Heizmann,et al. Excretion and metabolism of 14C-midazolam in humans following oral dosing. , 1981, Arzneimittel-Forschung.
[16] M. Newland,et al. Oral caffeine consumption by rats: The role of flavor history, concentration, concurrent food, and an adenosine agonist , 1992, Pharmacology Biochemistry and Behavior.
[17] J. Richards,et al. DRL interresponse-time distributions: quantification by peak deviation analysis. , 1993, Journal of the experimental analysis of behavior.
[18] P Heizmann,et al. Pharmacokinetics and bioavailability of midazolam in man. , 1983, British journal of clinical pharmacology.
[19] J. Falk,et al. Independent interaction of alprazolam and caffeine under chronic dose regimens on differential reinforcement of low-rate (DRL 45-s) performance , 1997, Psychopharmacology.
[20] J. Falk,et al. Sustained synergism by chronic caffeine of the motor control deficit produced by midazolam , 1991, Pharmacology Biochemistry and Behavior.